semaglutide ckd trial Indication Opportunity: From CDK, HFpEF to Alzheimer's disease Novo Nordisk's semaglutide shows promise

Offering a science-backed, nutrition-focused weight loss solution

The Heavy Price of GLP-1 Drugs reveals how pharmaceutical companies are exploiting the patent system, delaying competition, and driving up costs for patients

Codeage GLP-Harmony Companion+ supplement combines Lion's Mane, PEA, colostrum, shilajit, elder fruit, akkermansia, resveratrol, and other ingredients to offer a supplement to GLP-1 agonist users

The Harvest Healthcare Leaders Income ETF offers exposure to companies that are making progress in the burgeoning weight loss market.

Listen Labs' AI interviews reveal surprising trends, using real data to show consumer goods companies how they can adapt